Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Christ

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Blood Advances|October 23, 2023
Blinatumomab consolidation post-autologous stem cell transplantation in patients with diffuse large B-cell lymphomaArmin Ghobadi, Nicole C Foley, Jared Cohen, et al.
Open Forum Infectious Diseases|November 13, 2023
Duvelisib for Critically Ill Patients With Coronavirus Disease 2019: An Investigator-Initiated, Randomized, Placebo-Controlled, Double-Blind Pilot TrialScott R Goldsmith, Fahrettin Covut, Mark Fiala, et al.
Blood|April 13, 2017
Continuous blockade of CXCR4 results in dramatic mobilization and expansion of hematopoietic stem and progenitor cellsDarja Karpova, Julie K Ritchey, Matthew S Holt, et al.
Leukemia & Lymphoma|January 20, 2021
A phase I trial evaluating the effects of plerixafor, G-CSF, and azacitidine for the treatment of myelodysplastic syndromesEric Huselton, Michael P Rettig, Theresa Fletcher, et al.
Blood|March 16, 2017
Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graftMark A Schroeder, Michael P Rettig, Sandra Lopez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2026
NT-I7, a long-acting interleukin-7, increases lymphocyte counts and induces CD8+ T cell clonotype expansion in patients with newly diagnosed high-grade gliomasOmar H Butt, Kartik Singhal, Jingqin Luo, et al.
Research Square|August 16, 2024
Anti-CD7 allogeneic WU-CART-007 in patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma: a phase 1/2 trialArmin Ghobadi, Ibrahim Aldoss, Shannon Maude, et al.
The Journal of Clinical Investigation|May 16, 2019
Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cellsDarja Karpova, Michael P Rettig, Julie Ritchey, et al.
Blood|May 30, 2025
Phase 1/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed/refractory T-cell malignanciesArmin Ghobadi, Ibrahim Aldoss, Shannon L Maude, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Blood Advances|October 23, 2023
Blinatumomab consolidation post-autologous stem cell transplantation in patients with diffuse large B-cell lymphomaArmin Ghobadi, Nicole C Foley, Jared Cohen, et al.
Open Forum Infectious Diseases|November 13, 2023
Duvelisib for Critically Ill Patients With Coronavirus Disease 2019: An Investigator-Initiated, Randomized, Placebo-Controlled, Double-Blind Pilot TrialScott R Goldsmith, Fahrettin Covut, Mark Fiala, et al.
Blood|April 13, 2017
Continuous blockade of CXCR4 results in dramatic mobilization and expansion of hematopoietic stem and progenitor cellsDarja Karpova, Julie K Ritchey, Matthew S Holt, et al.
Leukemia & Lymphoma|January 20, 2021
A phase I trial evaluating the effects of plerixafor, G-CSF, and azacitidine for the treatment of myelodysplastic syndromesEric Huselton, Michael P Rettig, Theresa Fletcher, et al.
Blood|March 16, 2017
Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graftMark A Schroeder, Michael P Rettig, Sandra Lopez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2026
NT-I7, a long-acting interleukin-7, increases lymphocyte counts and induces CD8+ T cell clonotype expansion in patients with newly diagnosed high-grade gliomasOmar H Butt, Kartik Singhal, Jingqin Luo, et al.
Research Square|August 16, 2024
Anti-CD7 allogeneic WU-CART-007 in patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma: a phase 1/2 trialArmin Ghobadi, Ibrahim Aldoss, Shannon Maude, et al.
The Journal of Clinical Investigation|May 16, 2019
Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cellsDarja Karpova, Michael P Rettig, Julie Ritchey, et al.
Blood|May 30, 2025
Phase 1/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed/refractory T-cell malignanciesArmin Ghobadi, Ibrahim Aldoss, Shannon L Maude, et al.
Pageof 2